Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is primary urethral adenocarcinoma?
Primary urethral adenocarcinoma is an uncommon cancer that starts in the urethra — the tube that carries urine out of the body — and is made of gland-forming (mucus-producing) cells. It is a distinct subtype of urethral cancer; most urethral cancers are urothelial or squamous, while adenocarcinoma accounts for only a minority. It is thought to arise from glands in the urethral lining or, in some cases, from pockets of misplaced tissue. It is more common in women than men, partly because the female urethra contains more glandular tissue. Because the urethra is short and surrounded by important structures involved in continence and sexual function, treatment is carefully tailored to cure the cancer while preserving as much normal function as possible. Since it is rare, care is best delivered at an experienced center, often combining surgery, radiation, and chemotherapy.
The main types
Doctors group primary urethral adenocarcinoma by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Columnar / mucinous adenocarcinoma | The most common pattern, made of tall mucus-producing cells; often arises in the deeper, glandular part of the urethra. |
| Clear cell adenocarcinoma | A distinctive subtype, more common in women, that may arise from a urethral diverticulum (a small out-pouching); recognized by its clear-appearing cells under the microscope. |
| Adenocarcinoma arising in a diverticulum | Cancer that develops inside a urethral diverticulum, a fluid-filled pocket off the urethra; the pocket can hide the tumor and delay diagnosis. |
Staging, in plain terms
Urethral cancers, including adenocarcinoma, are staged with the TNM system: T describes how deeply the tumor has grown into the urethral wall and nearby tissue, N whether it has reached lymph nodes in the groin or pelvis, and M whether it has spread to distant organs. Because tumors near the opening tend to be found earlier than those deep inside, location strongly affects the outlook.
| Urethral cancer TNM staging | What it generally means |
|---|---|
| Stage 0/I | A small tumor confined to the innermost lining or just beneath it, with no spread. Often treatable with organ-sparing surgery or local therapy. |
| Stage II | The tumor has grown deeper into the supporting tissue of the urethra but has not reached lymph nodes. |
| Stage III | The tumor has invaded nearby structures (such as the bladder neck or vaginal/penile tissue) or has reached a regional lymph node. |
| Stage IV | The cancer has spread to multiple or distant lymph nodes or to distant organs. Treated with combined chemotherapy, radiation, and surgery in selected cases. |
The standard of care
Primary Urethral Adenocarcinoma is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Surgery
For tumors near the opening, organ-sparing local excision may suffice; deeper or more extensive tumors may require removing more of the urethra and, in advanced cases, nearby organs. A diverticulum-related tumor is removed along with the pocket.
Organ-preserving chemoradiation
Combining radiation with chemotherapy can control the cancer while sparing the urethra and continence, and is an increasingly favored alternative to extensive surgery for many patients.
Lymph node treatment
Groin and pelvic lymph nodes may be removed or irradiated when there is a risk they contain cancer, since node spread strongly affects outcome.
Chemotherapy
Multi-drug chemotherapy is used together with radiation for local control and on its own when the cancer has spread, sometimes before surgery to shrink the tumor.
How radiation treatment works
Radiation damages the DNA inside cancer cells so they can no longer divide, while healthy cells recover more effectively. For urethral adenocarcinoma, radiation — often combined with chemotherapy — can cure the cancer while preserving the urethra and urinary control, sparing many patients from extensive surgery. It is delivered as a series of short, painless daily sessions and, for external-beam treatment, leaves no radioactivity in your body, so you remain safe to be around family and children. When brachytherapy is used, your team will explain the brief safety precautions involved.
The main ways radiation is delivered for primary urethral adenocarcinoma:
External-beam radiation (IMRT)
Computer-shaped x-ray beams treat the urethra and at-risk lymph nodes while limiting dose to the bladder, rectum, and reproductive organs to protect function.
Brachytherapy
In selected cases, a radioactive source is placed very close to the tumor for a short time, delivering a high local dose while sparing surrounding tissue — useful for small, well-localized tumors.
Concurrent chemoradiation
Radiation given alongside chemotherapy that makes cancer cells more sensitive to the radiation, improving the chance of cure without removing the urethra.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Organ-preserving chemoradiation gains ground: Series and guideline reviews support combined chemotherapy and radiation as a way to cure many urethral cancers while preserving the urethra and continence, reserving radical surgery for treatment failures.[1]
NCCN and EAU urethral cancer guideline reviews (2023–2025)
Clear cell adenocarcinoma and diverticula: Studies clarify that clear cell adenocarcinoma of the female urethra often arises within diverticula, underscoring the importance of imaging and complete removal of the diverticulum.[2]
Urologic pathology case series (2022–2024)
Multimodal therapy for advanced disease: For node-positive and locally advanced tumors, combining chemotherapy, radiation, and selective surgery offers better local control than any single treatment alone.[3]
International rare-tumor consortium analyses (2023–2025)
Common questions
Will I lose the ability to urinate normally? Often, no. For many patients, organ-preserving treatment with radiation and chemotherapy can cure the cancer while keeping the urethra and urinary control intact. The plan depends on where the tumor is and how far it has grown, and your team will discuss the trade-offs with you.
What is a urethral diverticulum and why does it matter? A diverticulum is a small pocket that can form off the urethra. Some urethral adenocarcinomas — especially the clear cell type in women — arise inside one. Because the pocket can hide a tumor, imaging is used to find it, and the pocket is removed together with the cancer.
Is this related to bladder cancer? It can look similar under the microscope, but primary urethral adenocarcinoma starts in the urethra itself. Your team will confirm the urethra is the true origin, because that changes how the cancer is staged and treated.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.